The Science of Healthy Hair, Hair Loss, and How to Regrow Hair
Summary
This episode covers the complete biology of hair growth — from stem cells and hair follicle anatomy to the hormonal and mechanical factors that regulate growth cycles. Andrew Huberman explains why hair loss occurs with age, particularly through the action of dihydrotestosterone (DHT), and outlines a range of evidence-based interventions — both mechanical and chemical — to slow, halt, or reverse hair loss in men and women.
Key Takeaways
- Every hair has its own stem cell niche within the hair bulb; protecting and reactivating these stem cells is the central goal of most hair loss treatments.
- Hair loss is driven largely by DHT (dihydrotestosterone), which inhibits the growth-promoting signals IGF-1 and cyclic AMP, shortening the anagen (growth) phase.
- By age 50, approximately 50% of men and women experience noticeable hair loss, with loss beginning gradually around age 30.
- Minoxidil works primarily by increasing blood flow to the hair follicle stem cell niche, extending the anagen phase — but must be used indefinitely to maintain results.
- Microneedling (1–2.5mm needle depth) can reactivate semi-quiescent stem cells and, when combined with minoxidil, has shown effectiveness even in previously bald “dead zones.”
- The combination of minoxidil + microneedling is significantly more effective than either treatment alone.
- Scalp tension reduces blood flow to follicles; treatments like Botox injections and scalp massage aim to relieve this tension and improve circulation.
- DHT is not inherently harmful — it supports mental vigor, libido, strength, and drive — so managing DHT for hair loss requires careful, targeted approaches.
- The pattern of hair loss (front vs. crown vs. diffuse) is determined by the distribution of androgen receptors on the scalp, which is genetically inherited.
- The myth that you can predict balding from your mother’s father is false — the pattern of androgen receptors comes from the maternal line, but looking at your maternal grandmother would be more informative (and even that is imprecise).
Detailed Notes
Hair Follicle Anatomy
- Each hair has three components:
- Shaft — the visible portion above the skin
- Root — extends down through the epidermis into the dermis
- Hair bulb — the cave-like base containing stem cells and melanocytes
- The hair bulb contains:
- Stem cells (progenitor cells that divide via mitosis to produce daughter cells forming keratin)
- Melanocytes (produce melanin, the pigment that colors hair)
- Capillaries supplying oxygen and nutrients — essential for active hair growth
- Adjacent structures:
- Sebaceous gland — produces sebum, which waterproofs skin and provides antibacterial/antimicrobial protection
- Arrector pili muscle — contracts in response to cold or fear, causing goosebumps and trapping warm air between hairs
The Three Phases of Hair Growth
| Phase | Description | Duration (Scalp) |
|---|---|---|
| Anagen | Active growth; stem cells produce keratin proteins | 2–8 years |
| Catagen | Hair recedes from the bulb upward; growth stops | Varies |
| Telogen | Resting phase; stem cells become quiescent; hair may or may not return | Varies |
- Eyebrow anagen phase: only a few months (growing ~4.2mm/month), explaining why eyebrows don’t grow indefinitely.
- Hair “length” differences between people are more likely due to differences in anagen phase duration, not growth rate.
- After telogen, a follicle can re-enter anagen if stem cells remain viable, oxygen and blood flow are adequate, and hormonal conditions are favorable.
Hormonal Regulation of Hair Growth
Accelerators (extend anagen phase):
- IGF-1 (Insulin-like Growth Factor 1) — produced by the liver; extends the growth phase
- Cyclic AMP — a second messenger that supports stem cell activity and follicle growth
Brakes (shorten anagen or extend catagen/telogen):
- PDE (phosphodiesterase) — enzyme that limits cyclic AMP activity
- TGF-beta-2 — inhibits growth; promotes transition out of anagen
DHT and Androgen-Related Hair Loss:
- Testosterone is converted to DHT by the enzyme 5-alpha reductase
- DHT binds the androgen receptor at 5× the affinity of testosterone — making it the most potent androgen
- DHT inhibits IGF-1 and cyclic AMP, shortening the anagen phase and promoting catagen/telogen
- As people age, more 5-alpha reductase activity converts more testosterone to DHT, explaining why hair loss accelerates from around age 30–50
- DHT receptor density varies by scalp region, determining the pattern of hair loss (frontal, crown, diffuse)
- Women also produce testosterone and DHT; androgen-related alopecia affects both sexes
Treatment Approaches
Blood Flow / Mechanical Approaches
Minoxidil (Rogaine)
- Originally developed as an antihypertensive drug; promotes vasodilation
- Mechanism: increases blood flow to the hair follicle stem cell niche → extends anagen phase
- Routes: oral or topical (5% solution)
- Oral dosage range: 0.25 mg to 5 mg/day (start low and titrate up)
- Topical: 5% solution, applied once daily, leave on scalp 3–5 minutes
- Side effects: fluid retention/edema, dizziness, headache, elevated prolactin (which can reduce libido and well-being), gynecomastia at high doses
- Important: minoxidil is likely a lifelong commitment — stopping treatment typically results in loss of gains
- Topical minoxidil can still enter systemic circulation via follicle capillaries
Low-Dose Tadalafil (Cialis)
- Originally a prostate health drug; increases blood flow broadly
- Dosage for hair/scalp blood flow: 2.5–5 mg
- Mechanistically similar to minoxidil (vasodilation to stem cell niche)
- Fewer side effects than minoxidil; being prescribed by some doctors for hair maintenance
- Uses a roller with needles (0.5mm–2.5mm length) rolled across the scalp
- Mechanism: micro-injury triggers reactivation of semi-quiescent stem cells in telogen phase; stimulates local inflammation cascade → proliferation signals
- Needle lengths of 1–2.5mm appear more effective than shorter needles
- May cause minor bleeding and temporary scalp inflammation — this is part of the mechanism
- Combination with minoxidil is substantially more effective than either treatment alone
- The only approach shown to recover “dead zones” (completely bald regions) — but only when combined with minoxidil; recovery may take 30–50 weeks
- Supported by: “Microneedling and its Use in Hair Loss Disorders: A Systematic Review” (link provided in show notes)
Scalp Massage
- Transiently increases blood flow; unlikely to be sufficient alone but supportive as an adjunct
Botox (Botulinum Neurotoxin)
- Injected into the scalp to relieve tension/contraction of scalp skin
- Mechanism: reduces skin tension → improves blood flow to follicle niche
- Evidence from cutis verticis gyrata (ridged scalp skin with pattern hair loss): Botox relieved folds and improved hair growth
- Must be done by a skilled practitioner; wears off and requires repeat treatments
- Limited large-scale clinical data; considered a reasonable but more invasive option
PRP (Platelet-Rich Plasma)
- Blood is drawn, spun down, platelets extracted and re-injected into scalp
- Mechanism: enriched nutrient